| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.14 | 0.3 |